Aquatic Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
+207,774
| New | +$1.86M | 0.04% | 490 |
|
|
2025
Q1 | – | Sell |
-55,890
| Closed | -$420K | – | 1271 |
|
|
2024
Q4 | $420K | Sell |
55,890
-80,210
| -59% | -$603K | 0.01% | 758 |
|
|
2024
Q3 | $1.03M | Buy |
136,100
+122,400
| +893% | +$930K | 0.03% | 496 |
|
|
2024
Q2 | $84.7K | Buy |
13,700
+10,400
| +315% | +$64.3K | ﹤0.01% | 927 |
|
|
2024
Q1 | $16.8K | Sell |
3,300
-200
| -6% | -$1.02K | ﹤0.01% | 1113 |
|
|
2023
Q4 | $21K | Sell |
3,500
-61,100
| -95% | -$367K | ﹤0.01% | 1213 |
|
|
2023
Q3 | $457K | Buy |
64,600
+35,800
| +124% | +$253K | 0.02% | 499 |
|
|
2023
Q2 | $203K | Buy |
28,800
+7,800
| +37% | +$55K | 0.01% | 661 |
|
|
2023
Q1 | $175K | Sell |
21,000
-7,600
| -27% | -$63.3K | 0.01% | 622 |
|
|
2022
Q4 | $328K | Buy |
28,600
+22,000
| +333% | +$252K | 0.02% | 614 |
|
|
2022
Q3 | $83K | Buy |
6,600
+5,600
| +560% | +$70.4K | 0.01% | 801 |
|
|
2022
Q2 | $11K | Buy |
+1,000
| New | +$11K | ﹤0.01% | 951 |
|